Our results clearly indicate that circ-LRP6 functions as an oncogenic circRNA in ESCC by regulating miR-182/Myc axis, which provide a theoretical basis for it as a potential target of ESCC therapy. This evidence concerns the gene MYC and esophageal squamous cell carcinoma.